Evidence mapPaperPMID 40716112Full record

ArticleJournal of cachexia, sarcopenia and muscle2025

ODIASP: An Open-Source Software for Automated SMI Determination-Application to an Inpatient Population.

Katia Charrière, Antoine Ragusa, Béatrice Genoux, Antoine Vilotitch, Svetlana Artemova, Charlène Dumont, Paul-Antoine Beaudoin, Pierre-Ephrem Madiot, Gilbert R Ferretti, Ivan Bricault and 5 more

Abstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Sarcopenia and MASLD: novel insights and the future.Nature reviews. Endocrinology · 2026
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Katia CharrièrePublic Health Department, Univ. Grenoble Alpes, Clinical Investigation Center-Technological Innovation, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
Antoine RagusaUniv. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.
Béatrice GenouxPublic Health Department, Univ. Grenoble Alpes, Clinical Investigation Center-Technological Innovation, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
Antoine VilotitchUniv. Grenoble Alpes, Méthodologie de l'information en Santé, Biostatistiques, Recherche clinique et Innovation Technologique, Pôle Santé Publique, Unité d'ingénierie des données, Pôle Santé Publique, Grenoble Alpes University Hospital, Grenoble, France.
Svetlana ArtemovaUniv. Grenoble Alpes, Méthodologie de l'information en Santé, Biostatistiques, Recherche clinique et Innovation Technologique, Pôle Santé Publique, CHU Grenoble Alpes, Grenoble, France.
Charlène DumontPublic Health Department, Univ. Grenoble Alpes, Clinical Investigation Center-Technological Innovation, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
Paul-Antoine BeaudoinPublic Health Department, Univ. Grenoble Alpes, Clinical Investigation Center-Technological Innovation, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
Pierre-Ephrem MadiotUniv. Grenoble Alpes, Direction des Services Numériques, Grenoble Alpes University Hospital, Grenoble, France.
Gilbert R FerrettiUniv. Grenoble Alpes, INSERM U1209, IAB, CHU Grenoble Alpes, Service de radiologie diagnostique et interventionnelle, Grenoble, France.
Ivan BricaultUniv. Grenoble Alpes, INSERM U1209, IAB, CHU Grenoble Alpes, Service de radiologie diagnostique et interventionnelle, Grenoble, France.
Eric FontaineDepartment of Endocrinology, Diabetology and Nutrition, Univ. Grenoble Alpes, INSERM U1055, LBFA, CHU Grenoble Alpes, Grenoble, France.
Jean-Luc BossonPublic Health Department, Univ. Grenoble Alpes, Clinical Investigation Center-Technological Innovation, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
Alexandre Moreau-GaudryPublic Health Department, Univ. Grenoble Alpes, Clinical Investigation Center-Technological Innovation, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
Joris GiaiPublic Health Department, Univ. Grenoble Alpes, Clinical Investigation Center-Technological Innovation, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
Cécile BétryDepartment of Endocrinology, Diabetology and Nutrition, Univ. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France.ORCID 0000-0001-6729-2704

Funding

MIAI@Grenoble Alpes ANR-19-P3IA-0003Regional Delegation for Clinical Research of the University Hospital Grenoble Alpes in 2019
6 · The paper itself

Abstract

backgroundThe diagnosis of malnutrition has evolved with the GLIM recommendations, which advocate for integrating phenotypic criteria, including muscle mass measurement. The GLIM framework specifically suggests using skeletal muscle index (SMI) assessed via CT scan at the third lumbar level (L3) as a first-line approach. However, manual segmentation of muscle from CT images is often time-consuming and infrequently performed in clinical practice. This study is aimed at developing and validating an open-access, simple software tool called ODIASP for automated SMI determination.

methodsData were retrospectively collected from a clinical data warehouse at Grenoble Alpes University Hospital, including epidemiological and imaging data from CT scans. All consecutive adult patients admitted in 2018 to our tertiary centre who underwent at least one CT scan capturing images at the L3 vertebral level and had a recorded height were included. ODIASP combines two algorithms to automate L3 slice selection and skeletal muscle segmentation, ensuring a seamless process. Agreement between cross-sectional muscle area (CSMA) values obtained using ODIASP and the reference methodology (i.e., manual determination) was evaluated using the intraclass correlation coefficient (ICC). The prevalence of reduced SMI was also assessed.

resultsSMI was available for 2503 participants, 53.3% male, with a median age of 66 years (51-78) and a median BMI of 24.8 kg/m

conclusionsThis study demonstrates that ODIASP is a reliable tool for automated SMI at the L3 vertebra level from CT scans. The integration of validated AI algorithms into a simple, open-source software enables scalable, standardised assessment of SMI in diverse patient populations and supports future integration into clinical workflows for improved nutritional assessment.

Indexed as

Muscle, SkeletalSarcopeniaSoftwareAdultAgedAlgorithmsFemaleHumansInpatientsMaleMiddle AgedRetrospective StudiesTomography, X-Ray Computedbody compositioncomputational neural networkscomputer‐assistedimage processingmalnutritionsarcopeniaskeletal muscle

Identifiers

PMID40716112
PMCPMC12677933

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.